Inventurus Knowledge Solutions Share Price

Mumbai, Maharashtra, India Business Wire India

• Business Line
• 3 weeks 4 days ago

Applied research expertise will accelerate IKS Health's dynamic AI transformation

• Business Line
• 3 weeks 4 days ago

Healthcare Services company Inventurus Knowledge Solutions announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from Operations for Q4FY26 stood at Rs 8,576.52 million, an increase of 18.47% YoY compared to Rs 7,239.56 million in Q4FY25 and a growth of 5.24% QoQ from Rs 8,149.50 million in Q3FY26. Total Income for the quarter was Rs 8,625.25 million, registering a growth of 18.61% YoY from Rs 7,272.17 million and a growth of 5.12% QoQ from Rs 8,205.03 million. Profit before tax (PBT) for Q4FY26 reached Rs 2,529.55 million, marking an increase of 40.46% YoY compared to Rs 1,800.85 million and 10.28% QoQ over Rs 2,293.70 million. Profit for the period (PAT) for Q4FY26 was Rs 2,059.68 million, reflecting an increase of 39.35% YoY from Rs 1,478.02 million and a growth of 12.35% QoQ from Rs 1,833.28 million. For FY26, Consolidated Revenue from Operations was Rs 31,937.88 million, up 19.89% from Rs 26,639.94 million in FY25. Annual Consolidated Profit for the period (PAT) for FY26 stood at Rs 7,215.54 million, a significant growth of 48.45% compared to Rs 4,860.59 million in FY25. Standalone Financial Highlights: Revenue from Operations for Q4FY26 was Rs 4,126.91 million, up 42.13% YoY from Rs 2,903.67 million and up 2.27% QoQ from Rs 4,035.28 million. Total Income for the quarter stood at Rs 4,141.44 million, an increase of 41.80% YoY compared to Rs 2,920.59 million and a growth of 2.15% QoQ from Rs 4,054.09 million. Profit before tax (PBT) for Q4FY26 reached Rs 1,983.50 million, reflecting a YoY growth of 64.17% from Rs 1,208.16 million and a QoQ growth of 7.29% from Rs 1,848.69 million. Profit for the period (PAT) for the quarter was Rs 1,690.05 million, increasing by 69.32% YoY from Rs 998.11 million and 15.57% QoQ from Rs 1,462.40 million. For FY26, Standalone Revenue from Operations was Rs 14,913.79 million compared to Rs 9,730.83 million in FY25. Annual Standalone Profit for the period for FY26 reached Rs 5,665.19 million, representing a growth of 70.66% over Rs 3,319.48 million in FY25. Business Highlights: Segment Performance: The Group operates in a single reportable business segment, which is a Care enablement platform providing technology-enabled solutions to Healthcare providers. Acquisition of TruBridge, Inc.: Inventurus Knowledge Solutions, Inc., a wholly-owned subsidiary, entered into a definitive agreement on April 23, 2026, to acquire TruBridge, Inc. (a US-based provider of healthcare technology solutions) for an enterprise value of up to USD 565 million. Acquisition of Arai Solutions Private Limited: The Company approved the acquisition of 100% share capital of Arai Solutions Private Limited for a total cash consideration of Rs 11,00,00,000 (Indian Rupees Eleven crore only). The target entity provides AI-focused consultancy services and software development in the healthcare space. Arai Solutions Private Limited Financials: For FY26, the target entity recorded Revenue from operations of Rs 5,462,600 and Total income of Rs 5,538,394, with a Net worth of Rs 956,433. Foreign Exchange Gains: The consolidated results for FY26 included a net foreign exchange gain of Rs 627.47 million, while the standalone results recorded a net gain of Rs 447.32 million. These gains primarily relate to exchange differences arising on the realization and restatement of foreign currency denominated trade receivables and cash and bank balances. Management Changes: Following a review of internal roles, Mr. Saransh Mundra will no longer be classified as Senior Management Personnel effective May 14, 2026, but will remain an integral part of the organization responsible for investor relations. Associate Incorporation: The consolidated financial results from the quarter ended September 30, 2025, include the share of profit/loss from IKS WWMG MSO, LLC, an associate company. Employee Stock Options: During FY26, the Company allotted 4,72,514 shares to eligible employees on the exercise of stock options under the IKS Health-ESOP Policy 2022. Additionally, the Company granted a total of 40,66,500 stock options to employees during the year. Sachin K. Gupta, Founder & CEO, IKS Health, said: “Our performance this fiscal year underscores the deep value we bring to clinician enterprises as they navigate an increasingly complex US healthcare landscape. Ending the year with a strong 20% YoY revenue growth in FY26 is a testament to the scalability of our care enablement platform.” “Our 'AI + Human' model is now the industry standard for sustainable growth, as proven by our expanding partnerships with top-tier health systems. By deploying autonomous engines and agentic AI like MyCareHub™, we are providing the clinical and financial intelligence needed to transform care delivery. We enter FY27 with the financial strength to accelerate this AI-driven momentum.” Nithya Balasubramanian, CFO, IKS Health, said: “Our fiscal year concluded with exceptional operational discipline, reflected in our 38% YoY EBITDA growth and significant margin expansion. The 48% rise in PAT for the year demonstrates our ability to scale efficiently and deliver profitable growth through a resilient business model which leverages the latest technology and global delivery. With a strong balance sheet and robust cash flow generation, we are well-positioned to continue investing in our technology platform to drive long-term, sustainable value for our shareholders.” Result PDF

• Trendlyne
• 3 weeks 5 days ago